Letters to the Editor

Klink letter: Epipen costs

Regarding Mylan Pharmaceutical’s Epipen:

When someone eventually dies because they or their parents couldn’t afford the product, why shouldn’t their CEO be charged with manslaughter?

Paul Klink, Boise

  Comments